Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Prevalence of Non-Adherence in Patients with Resistant Hypertension: a Systematic Review and Meta-Analysis

Gabrielle Bourque, Julius Vladimir Ilin, Marcel Ruzicka, Alexandra Davis, Gregory Hundemer, View ORCID ProfileSwapnil Hiremath
doi: https://doi.org/10.1101/2020.08.14.20175125
Gabrielle Bourque
1The Ottawa Hospital and the University of Ottawa, 501 Smyth Road Ottawa, ON, Canada K1H8L6
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julius Vladimir Ilin
2The University of Ottawa, 451 Smyth Road Ottawa, ON, Canada K1H8L1
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel Ruzicka
3The Ottawa Hospital and the University of Ottawa, 1967 Riverside Drive Ottawa, ON, Canada K1H7W9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Davis
4The Ottawa Hospital, 501 Smyth Road Ottawa, ON, Canada K1H8L6
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Hundemer
3The Ottawa Hospital and the University of Ottawa, 1967 Riverside Drive Ottawa, ON, Canada K1H7W9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swapnil Hiremath
3The Ottawa Hospital and the University of Ottawa, 1967 Riverside Drive Ottawa, ON, Canada K1H7W9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Swapnil Hiremath
  • For correspondence: shiremath@toh.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Resistant hypertension is quite prevalent and a risk factor for cardiovascular events. Patients with suspected resistant hypertension undergo more screening intensity for secondary hypertension, despite some of them being non-adherent to prescribed pharmacotherapy. The prevalence of non-adherence in this setting varies from about 5 to 80% in the published literature. Apart from the wide range, the relation between method of assessment and prevalence is not well established. Our objective was to establish the overall prevalence of non-adherence in the apparent treatment resistant hypertension population, explore causes of heterogeneity, and evaluate the effect of the method of assessment on the estimate of non-adherence.

Methods We performed a systematic review and meta-analysis. MEDLINE, EMBASE Classic+EMBASE, Cochrane, CINAHL, and Web of Science were searched for relevant articles. Details about the method of adherence assessment were extracted from each included article and grouped into direct and indirect. Pooled analysis was performed using the random effects model and heterogeneity was explored with metaregression and subgroup analyses.

Results The literature search yielded 1428 studies, of which 36 were included. The pooled prevalence of non-adherence was 35% (95% confidence interval 25 – 46 %). For indirect methods of adherence assessment, it was 25% (95% CI 15 – 39 %), whereas for direct methods of assessment, it was 44% (95% CI 32 – 57 %). Metaregression suggested gender, age, and time of publication as potential factors contributing to the heterogeneity.

Conclusions Non-adherence to pharmacotherapy is quite common in resistant hypertension, with the prevalence varying with the methods of assessment.

Brief Summary Resistant hypertension is known to be a risk factor for cardiovascular events. These patients also undergo higher screening intensity for secondary hypertension. However, not all patients with apparent treatment resistant hypertension have true resistant hypertension, with some of them being non-adherent to prescribed pharmacotherapy. This systematic review aims to establish the overall prevalence of non-adherence in the apparent treatment resistant hypertension population and assess the relative contributions of non-adherence assessed with direct and indirect measures.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

CRD42020137944

Funding Statement

No direct funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Systematic Review, no IRB approval necessary

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • gabourque{at}toh.ca, jilin016{at}uottawa.ca, mruzicka{at}toh.ca, adavis{at}toh.ca, ghundemer{at}toh.ca

Data Availability

We only use publicly available data

  • LIST OF ABBREVIATIONS

    ABPM
    Ambulatory Blood Pressure Monitoring
    BP
    Blood Pressure
    CHF
    Congestive Heart Failure
    CI
    Confidence Interval
    CINHAL
    Cumulative Index of Nursing and Allied Health Literature
    CKD
    Chronic Kidney Disease
    CVD
    Cerebrovascular Disease
    DBP
    Diastolic Blood Pressure
    DOT
    Directly Observed Therapy
    HR
    Heart Rate
    MARS
    Medication Adherence Report Scale
    MEMS
    Medication Event Monitoring System
    MMAS
    Morisky Medication Adherence Scale
    PDC
    Proportion of Days Covered
    PRISMA
    Preferred Reporting Items for Systematic Reviews and Meta-Analyses
    RCTs
    Randomized Controlled Trials
    RH
    Resistant Hypertension
    SBP
    Systolic Blood Pressure
    TDM
    Therapeutic Drug Monitoring
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted August 16, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    The Prevalence of Non-Adherence in Patients with Resistant Hypertension: a Systematic Review and Meta-Analysis
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    The Prevalence of Non-Adherence in Patients with Resistant Hypertension: a Systematic Review and Meta-Analysis
    Gabrielle Bourque, Julius Vladimir Ilin, Marcel Ruzicka, Alexandra Davis, Gregory Hundemer, Swapnil Hiremath
    medRxiv 2020.08.14.20175125; doi: https://doi.org/10.1101/2020.08.14.20175125
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    The Prevalence of Non-Adherence in Patients with Resistant Hypertension: a Systematic Review and Meta-Analysis
    Gabrielle Bourque, Julius Vladimir Ilin, Marcel Ruzicka, Alexandra Davis, Gregory Hundemer, Swapnil Hiremath
    medRxiv 2020.08.14.20175125; doi: https://doi.org/10.1101/2020.08.14.20175125

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (214)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1091)
    • Dentistry and Oral Medicine (194)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
    • Epidemiology (9747)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2299)
    • Geriatric Medicine (221)
    • Health Economics (461)
    • Health Informatics (1548)
    • Health Policy (729)
    • Health Systems and Quality Improvement (600)
    • Hematology (236)
    • HIV/AIDS (500)
    • Infectious Diseases (except HIV/AIDS) (11623)
    • Intensive Care and Critical Care Medicine (615)
    • Medical Education (236)
    • Medical Ethics (67)
    • Nephrology (256)
    • Neurology (2137)
    • Nursing (133)
    • Nutrition (332)
    • Obstetrics and Gynecology (424)
    • Occupational and Environmental Health (516)
    • Oncology (1171)
    • Ophthalmology (363)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (145)
    • Palliative Medicine (50)
    • Pathology (308)
    • Pediatrics (693)
    • Pharmacology and Therapeutics (298)
    • Primary Care Research (265)
    • Psychiatry and Clinical Psychology (2168)
    • Public and Global Health (4640)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (451)
    • Respiratory Medicine (622)
    • Rheumatology (273)
    • Sexual and Reproductive Health (224)
    • Sports Medicine (208)
    • Surgery (250)
    • Toxicology (42)
    • Transplantation (120)
    • Urology (94)